Diagnostic Considerations in the Evaluation of Large B-Cells on Lymph Node Cytology Specimens

Daniel F Boyer1, Sarah Choi1, Winston Lee1

  • 1Department of Pathology, University of Michigan Hospital and Health System, Ann Arbor, Michigan, USA.

Acta Cytologica
|September 4, 2020
PubMed

Insights

Fine needle aspiration (FNA) aids lymph node evaluation for lymphoproliferative disorders. However, accurately subclassifying lymphoma requires more than morphology, highlighting the role of Epstein-Barr virus (EBV) DNA testing.

Area of Science:

  • Oncology
  • Pathology
  • Virology

Background:

  • Fine needle aspiration (FNA) is a common method for evaluating lymph nodes in suspected lymphoproliferative disorders.
  • Morphological assessment alone has limitations in accurately subclassifying lymphomas.
  • Accurate diagnosis is crucial for appropriate patient management and treatment.

Observation:

  • This case report focuses on the diagnostic challenges of large B-cell populations identified via FNA.
  • The study explores the utility of Epstein-Barr virus (EBV) DNA detection in FNA samples.
  • It highlights the importance of integrating molecular findings with cytomorphology.

Findings:

  • Morphological limitations in lymphoma subclassification using FNA are acknowledged.
  • The presence and significance of Epstein-Barr virus (EBV) DNA in FNA material are discussed.
  • Expanding diagnostic considerations for large B-cell lymphomas on FNA is addressed.

Implications:

  • This work aims to improve the diagnostic accuracy of lymphoma subclassification from FNA specimens.
  • It emphasizes the value of molecular markers like EBV DNA in conjunction with cytopathology.
  • The findings may guide clinicians and pathologists in managing patients with suspected lymphoma.